ImmunoPrecise Announces Debt Settlement of Previously Issued Debentures Canada NewsWire VICTORIA, March 6...
ImmunoPrecise Announces Artificial Intelligence Collaboration with EVQLV to Accelerate Vaccine and Antibody...
L'OCRCVM permet la reprise de la négociation - IPA Canada NewsWire VANCOUVER, le 20 févr. 2020 VANCOUVER, le 20 févr. 2020 /CNW/...
IIROC Trading Resumption - IPA Canada NewsWire VANCOUVER, Feb. 20, 2020 VANCOUVER, Feb. 20, 2020 /CNW/ - Trading resumes in: Company:...
Suspension de la négociation par l'OCRCVM - IPA Canada NewsWire VANCOUVER, le 20 févr. 2020 VANCOUVER, le 20 févr. 2020 /CNW/...
IIROC Trading Halt - IPA Canada NewsWire VANCOUVER, Feb. 20, 2020 VANCOUVER, Feb. 20, 2020 /CNW/ - The following issues have been halted by...
ImmunoPrecise Launches Coronavirus Vaccine and Therapeutic Antibody Program Canada NewsWire VICTORIA, Feb. 20...
ImmunoPrecise integrates SGI-DNA's benchtop automated DNA printer to accelerate antibody discovery and...
ImmunoPrecise Subsidiary Joins Genmab and Merus in Expansion to new Biotech Accelerator at the Center of...
ImmunoPrecise Antibodies Will Be in San Francisco During J.P. Morgan Healthcare Conference Week January 13-16...
ImmunoPrecise Announces Record Quarterly Revenue and Significantly Expands Gross Margins Canada...
ImmunoPrecise Announces Annual General Meeting Results Canada NewsWire VICTORIA, Dec. 2, 2019 VICTORIA, Dec...
Talem Therapeutics accesses the OmniAb® platform from Ligand Pharmaceuticals Canada NewsWire VICTORIA...
ImmunoPrecise Adopts Shareholder Rights Plan Canada NewsWire VICTORIA, Oct. 18, 2019 VICTORIA, Oct. 18, 2019...
ImmunoPrecise Strengthens Board of Directors with Antibody Business Leader, Brian Lundstrom Canada...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.